The CCR6 gene helps guide certain immune cells to places like the skin, gut, and airways, where they respond to signals of irritation or infection. If it does not work well, immune cells may not move in a balanced way, which can affect inflammation and the body’s defense at barrier tissues. Many variants in this gene are harmless, while a few may slightly influence the chance of conditions such as psoriasis or inflammatory bowel disease.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for producing proteins, which do much of the cells’ work. Others mainly guide when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, more information is available in the LearnHub.
Overview
CCR6Gene function
What if the gene works
The CCR6 gene helps guide certain immune cells to the skin, gut, lungs, and other barrier tissues where germs often enter. This supports normal immune defense and helps control inflammation.
Risk
What if the gene does not work
Changes in the CCR6 gene can reduce the CCR6 receptor, so some immune cells respond less well to guiding chemical signals. Milder variants may partly weaken this signaling, while more severe variants can disrupt cell movement more clearly.
Treatment
What does that mean for your treatment
No CCR6-specific treatment or drug-choice approach is currently established in clinical guidelines for people with pathogenic variants in the CCR6 gene. The CCR6 gene and the CCL20-CCR6 pathway are being studied as possible drug targets and disease activity markers in immune conditions and some cancers.
Conditions associated with CCR6
Gene function
What if the gene works
Your immune cells use the CCR6 gene to follow chemical signals to the places they are needed most. It is especially important in cells that patrol the skin, gut, airways, and other body linings. This helps explain how the immune system stays organized during everyday defense.
The CCR6 gene gives certain immune cells a surface receptor, which is a kind of receiver, for a chemical signal called CCL20. This lets those cells detect where they are being called.
After sensing CCL20, immune cells can move toward tissues that need routine surveillance or a focused response. This is a key part of the CCR6 gene’s role in immune cell movement.
CCR6 guided cells often gather in the skin, gut, airways, and other body linings that meet the outside world. This supports everyday immune defense at these barrier surfaces.
This gene also helps immune cells settle into the right areas within tissues and lymph nodes. Good positioning supports clearer communication between cells during normal immune activity.
What is a variant?
A genetic variant is a slight change in the DNA sequence within a gene. These changes are common and contribute to normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions to a greater extent and may contribute to, or cause, a genetic condition.
Genetic variants
What if the gene does not work
In studies of how variants in the CCR6 gene affect cell signaling, some changes lower how much receptor a cell makes or weaken how it folds, reaches the cell surface, or responds to its chemical messenger. Milder variants may partly reduce signaling, while more severe variants can leave little or no working receptor on the cell membrane. Some noncoding variants act earlier, changing how strongly the CCR6 gene is switched on rather than altering the protein itself.
How variants are linked to conditions
Studies most consistently link variants in the CCR6 gene to autoimmune and inflammatory conditions. In research on CCR6 gene variants linked to autoimmune conditions, the strongest evidence is for inflammatory bowel disease, psoriasis, rheumatoid arthritis, and vitiligo. These are risk associations seen across populations, so carrying a CCR6 variant may change risk but does not mean you will develop one of these conditions.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CCR6 gene itself. Some changes near CCR6 have been linked with a higher chance of certain immune-related conditions, but overall risk still depends on many other genes and everyday factors.
Inheritance of CCR6 variants
There is not yet a broadly confirmed Mendelian pattern for how CCR6 gene variants are inherited in a specific CCR6 related condition, because most reported links involve complex traits where many genes and life factors work together. In practical terms, how CCR6 gene variants are inherited is usually as part of the usual mix of DNA passed down through families rather than a single well-established dominant or recessive pattern. The CCR6 gene is located on chromosome 6, which is an autosome, so you inherit one copy from each parent.
What does my CCR6 result mean for my family?
There is not yet a broadly confirmed inherited pattern for CCR6 tied to a specific single-gene condition. Most CCR6 findings are discussed as part of risk, not as a clear-cut result that predicts the same health issue in relatives. If you have a specific CCR6 result and want to know what it could mean for your family, a doctor or genetic counselor can help put it in context.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the CCR6 gene, a lab uses genetic testing on blood, saliva, or a cheek swab. Genetic testing for variants in the CCR6 gene reads the DNA sequence and compares it with the usual version. Results may show a benign variant, a variant of uncertain significance, or a change linked to health risk.
When should I consider getting a genetic test?
There isn't yet a broadly established CCR6-specific reason to get genetic testing in routine care. Testing decisions are usually based on your personal health history, symptoms, and family history, often using broader genetic panels rather than looking at CCR6 alone.
A genetic result is only one part of your health story
Genetic test results can be informative, although how much they reveal varies with the condition and the kind of variant involved. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as response to medication, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. Part of the reason is that inherited differences can change how the body absorbs, breaks down, or responds to a drug, and this kind of variation is common.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic variation affects a person’s response to medicines. By looking at links between genes and medications, it helps explain why the same treatment can work differently from one person to another. For many drugs, genes influence both how strongly a medicine works and how the body handles it. Understanding this can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the CCR6 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so questions about symptoms, side effects, or treatment changes are best discussed with your doctor.
History
In the late 1990s, researchers identified the CCR6 gene during a period of rapid discovery of immune signaling genes. It was first described as part of the growing chemokine receptor family, a group that helped reshape how scientists understood immune cell movement. Building on this early work, scientists connected the CCR6 gene with its matching signal, CCL20, which gave the field a clearer map of this pathway. In the years that followed, CCR6 drew more attention as studies linked it to inflammatory conditions such as psoriasis, inflammatory bowel disease, and rheumatoid arthritis. Over time, genetic studies refined the picture, making the CCR6 gene a steady part of modern research on immunity and inflammation.